| Description: |
1. Mr. Kwakwa and Mr. Randolph will meet with WIPO Re:Search (WRS) coalition partner BVGH in Seattle to review strategic objectives for the coming year. The review is based on the WRS Strategic Plan 2017-2021.
2. While on the U.S. West Coast, Mr. Kwakwa and Mr. Randolph will travel to
San Francisco for a one day visit with Gilead Pharmaceuticals, with the goal of recruiting the company as a new funding member of WRS. The day in San Francisco may include a visit to a Research and Development (R&D) facility.
3. On return to Geneva, both Mr. Kwakwa and Mr. Randolph plan to stop in New York to meet with WRS Advisory Committee member Mr. Roy Waldron, Chief IP counsel at Pfizer. |